IONIS PHARMACEUTICALS INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ionis Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Ionis Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $23.6M, a 95.2% decline year-over-year.
  • Ionis Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $644M.
  • Ionis Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$55.3M, a 122% decline from 2021.
  • Ionis Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $246M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $644M +$699M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 -$55.3M -$301M -122% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $246M +$843M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 -$597M -$697M -696% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 $100M -$376M -79% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $476M +$247M +108% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $229M +$218M +1911% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $11.4M -$13.3M -53.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $24.7M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2011 -$672K -$5.37M -114% Jan 1, 2011 Dec 31, 2011 10-K 2012-02-29
2010 $4.7M Jan 1, 2010 Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.